Baxalta Inc
DelistedCIK 1620546fmd_0SNQYNZAPC3ZET1CA2H28E6C1ZManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2012 to Mar 31, 2016, 11 periods
| Line item | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|
| Total revenues | 5,310 | 5,555 | 5,952 | 6,148 |
| Cost of revenue | 2,240 | 2,329 | 2,443 | 2,386 |
| Gross profit | 3,070 | 3,226 | 3,509 | 3,762 |
| Research and development | 581 | 595 | 820 | 1,176 |
| Selling, general and administrative | 913 | 1,017 | 1,053 | 1,442 |
| Interest expense | – | – | – | 51 |
| Interest and investment income | – | – | – | 3 |
| Other non-operating income (expense) | (15) | (1) | (104) | 102 |
| Income before taxes | 1,561 | 1,613 | 1,532 | 1,198 |
| Income tax expense | 356 | 325 | 346 | 270 |
| Net income from continuing operations | 1,205 | 1,288 | 1,186 | 928 |
| Net income | 1,248 | 1,288 | 1,737 | 956 |